MedPath

THE HIV NETHERLANDS AUSTRALIA THAILAND RESEARCH COLLABORATION

🇹🇭Thailand
Ownership
Private
Employees
-
Market Cap
-
Website

Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®

Phase 1
Withdrawn
Conditions
HIV Infections
Interventions
Drug: generic GPO saquinavir and novir vs invirase and norvir
First Posted Date
2008-02-22
Last Posted Date
2015-03-26
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Registration Number
NCT00622141

Pharmacokinetics of Low Dose Ritonavir

Phase 1
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2008-02-22
Last Posted Date
2012-04-05
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
20
Registration Number
NCT00622206
Locations
🇹🇭

HIV-NAT, Bangkok, Thailand

Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy

Completed
Conditions
HIV Infections
First Posted Date
2007-08-03
Last Posted Date
2020-07-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
700
Registration Number
NCT00511056
Locations
🇹🇭

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs

Not Applicable
Completed
Conditions
HIV Infections
Interventions
Procedure: salvage therapy
First Posted Date
2007-05-23
Last Posted Date
2020-07-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
95
Registration Number
NCT00477308
Locations
🇹🇭

Chulalongkorn Hospital, Bangkok, Thailand

🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

🇹🇭

Queen Sirikit National Institute of Child Health, Bangkok, Bangkok, Thailand

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Phase 2
Completed
Conditions
HIV Infections
Tuberculosis
Interventions
First Posted Date
2007-05-22
Last Posted Date
2020-07-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
42
Registration Number
NCT00476853
Locations
🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

🇹🇭

Chiangrai Hospital, Chiang Rai, Thailand

🇹🇭

Mae Chan Hospital, Chiang Rai, Thailand

and more 3 locations

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Phase 2
Completed
Conditions
Hepatitis B Virus
HIV Infections
Interventions
First Posted Date
2007-05-22
Last Posted Date
2016-02-22
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
24
Registration Number
NCT00476463
Locations
🇹🇭

HIV-NAT Thai Red Cross AIDS Research Center, Bangkok, Thailand

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Phase 2
Withdrawn
Conditions
Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID
Interventions
First Posted Date
2007-05-22
Last Posted Date
2015-03-30
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Registration Number
NCT00476983

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

Completed
Conditions
HIV
Hepatitis-B
First Posted Date
2007-05-22
Last Posted Date
2010-06-07
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
36
Registration Number
NCT00476723
Locations
🇹🇭

HIV-NAT, Bangkok, Thailand

A Prospective Cohort of Children With HIV Infection

Completed
Conditions
HIV Infections
Interventions
Drug: Zidovudine, Stavudine, Didanosine, Lamivudine
Drug: LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
First Posted Date
2007-05-22
Last Posted Date
2025-03-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
500
Registration Number
NCT00476606
Locations
🇹🇭

HIV-NAT, Bangkok, Thailand

🇹🇭

Pediatric infectious diseases section, Chulalongkorn University, Bangkok, Thailand

🇹🇭

Khon Kaen University, Khon Kaen, Thailand

Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: GPO ritonavir versus Norvir
First Posted Date
2007-05-22
Last Posted Date
2012-04-05
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
16
Registration Number
NCT00477126
Locations
🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath